West Pharmaceutical Services (WST) Return on Capital Employed (2010 - 2026)
West Pharmaceutical Services (WST) posted Return on Capital Employed of 19.71% for Q2 2026, up 5.78% sequentially from 18.63% in Q1 2026, and up 142.0% YoY from 8.14% in Q2 2025.
West Pharmaceutical Services (WST) Return on Capital Employed (2010 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Return on Capital Employed for 17 years, with the latest figure at 19.71% in Q2 2026.
- Quarterly Return on Capital Employed rose 142.0% year-over-year to 19.71% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 19.71% (up 142.0% YoY) and the FY2025 annual result came in at 17.71%, down 17.0% from the prior year.
- Return on Capital Employed advanced to 19.71% in Q2 2026 per WST's latest filing, from 18.63% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 28.36% in Q2 2022 and troughed at 16.56% in Q4 2025.
- A 5-year average of 21.11% and a median of 20.22% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed jumped 653 bps in 2022, then sank 783 bps in 2023.
- Over 5 years, Return on Capital Employed stood at 24.9% in 2022, then decreased by 13 bps to 21.66% in 2023, then slipped by 15 bps to 18.33% in 2024, then dropped by 10 bps to 16.56% in 2025, then climbed by 19 bps to 19.71% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 19.71%, 18.63%, and 16.56% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.28% |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 12.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.71% |
| Mar 31, 2026 | 18.63% |
| Dec 31, 2025 | 16.56% |
| Sep 30, 2025 | 17.32% |
| Jun 30, 2025 | 18.28% |
| Mar 31, 2025 | 17.85% |
| Dec 31, 2024 | 18.33% |
| Sep 30, 2024 | 18.63% |
| Jun 30, 2024 | 20.16% |
| Mar 31, 2024 | 20.98% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 20.29% |
| Jun 30, 2023 | 20.52% |
| Mar 31, 2023 | 22.31% |
| Dec 31, 2022 | 24.90% |
| Sep 30, 2022 | 27.35% |
| Jun 30, 2022 | 28.36% |
| Mar 31, 2022 | 28.18% |
| Dec 31, 2021 | 28.56% |
| Sep 30, 2021 | 27.60% |